| Owens David |
Chief Medical Officer |
Nexalin Technology, Inc. (NXL)
|
2025-02-04 |
$2.98 |
0.0% |
1,000
|
$2,980 |
| Owens David |
Chief Medical Officer |
Nexalin Technology, Inc. (NXL)
|
2025-02-04 |
$3.10 |
0.0% |
1,000
|
$3,100 |
| Owens David |
Chief Medical Officer |
Nexalin Technology, Inc. (NXL)
|
2025-01-28 |
$2.70 |
0.0% |
1,500
|
$4,050 |
| Owens David |
Chief Medical Officer |
Nexalin Technology, Inc. (NXL)
|
2025-01-23 |
$2.57 |
0.0% |
3,000
|
$7,700 |
| Owens David |
Chief Medical Officer |
Nexalin Technology, Inc. (NXL)
|
2024-10-28 |
$2.19 |
0.0% |
500
|
$1,095 |
| Owens David |
Chief Medical Officer |
Nexalin Technology, Inc. (NXL)
|
2024-08-13 |
$0.95 |
-10.6% |
1,000
|
$950 |
| Owens David |
Chief Medical Officer |
Nexalin Technology, Inc. (NXL)
|
2024-06-28 |
$1.75 |
-51.5% |
1,000
|
$1,750 |
| Owens David |
Chief Medical Officer |
Nexalin Technology, Inc. (NXL)
|
2024-06-18 |
$0.71 |
19.7% |
1,619
|
$1,149 |
| Owens David |
Chief Medical Officer |
Nexalin Technology, Inc. (NXL)
|
2024-06-10 |
$0.64 |
32.7% |
3,000
|
$1,920 |
| Owens David |
Chief Medical Officer |
Nexalin Technology, Inc. (NXL)
|
2022-09-16 |
$4.15 |
-79.5% |
2,500
|
$10,375 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-23.9% |
$-8,397 |
$35,069 |